Aberrant hypomethylated STAT3 was identified as a biomarker of chronic benzene poisoning through integrating DNA methylation and mRNA expression data

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 346-353

  Yang, Jing ^a   Bai, Wenlin ^a   Niu, Piye ^a   Tian, Lin ^a   Gao, Ai ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Chronic benzene poisoning; DNA methylation; STAT3

Indexed keywords

ADIPOCYTOKINE; BENZENE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; EPHRIN RECEPTOR A8; GAMMA INTERFERON RECEPTOR 1; JANUS KINASE; MESSENGER RNA; RNA POLYMERASE II; STAT3 PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC BENZENE POISONING; CONTROLLED STUDY; DNA METHYLATION; EPHA8 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IFNGR1 GENE; INTOXICATION; MOLECULAR PATHOLOGY; PARD3 GENE; PRKG1 GENE; RNA POLYMERASE II GENE; SIGNAL TRANSDUCTION; STAT3 GENE; TRANSCRIPTION REGULATION;

BIOMARKERS; CHRONIC BENZENE POISONING; DNA METHYLATION; STAT3;

ADIPOKINES; ADULT; BENZENE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RECEPTOR, EPHA8; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84898914404     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.02.013     Document Type: Article

References (45)

1. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene Ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25-29.
2. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 2009, 21(2):243-251. (Apr).
3. Baccarelli A., Wright R., Bollati V., Litonjua A., Zanobetti A., Tarantini L., Sparrow D., Vokonas P., Schwartz J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 2010, 21:819-828.
4. Bibikova M., Barnes B., Tsan C., Ho V., Klotzle B., Le J.M., Delano D., Zhang L., Schroth G.P., Gunderson K.L., Fan J.B., Shen R. High density DNA methylation array with single CpG site resolution. Genomics 2011, 98(4):288-295.
5. Bollati V., Baccarelli A., Hou L., Bonzini M., Fustinoni S., Cavallo D., Byun H.M., Jiang J., Marinelli B., Pesatori A.C., Bertazzi P.A., Yang A.S. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007, 67(3):876-880.
6. Clarke R., Ressom H.W., Wang A., Xuan J., Liu M.C., Gehan E.A., et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat. Rev. Cancer 2008, 8:37-49.
7. Draghici S., Khatri P., Tarca A.L., Amin K., Done A., Voichita C., Georgescu C., Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007, 17:1537-1545.
8. Dupuy D., Bertin N., Hidalgo C.A., Venkatesan K., Tu D., Lee D., Rosenberg J., Svrzikapa N., Blanc A., Carnec A., Carvunis A.R., Pulak R., Shingles J., Reece-Hoyes J., Hunt-Newbury R., Viveiros R., Mohler W.A., Tasan M., Roth F.P., Le Peuch C., Hope I.A., Johnsen R., Moerman D.G., Barabási A.L., Baillie D., Vidal M. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat. Biotechnol. 2007, 25:663-668.
9. Fan G., Martinowich K., Chin M.H., He F., Fouse S.D., Hutnick L., Hattori D., Ge W., Shen Y., Wu H., ten Hoeve J., Shuai K., Sun Y.E. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development 2005, 132(15):3345-3356.
10. Gao A., Zuo X., Liu Q., Lu X., Guo W., Tian L. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. Toxicol. Lett. 2010, 195(2-3):114-118.
11. Gao A., Zuo X., Song S.S., Guo W., Tian L. Epigenetic modification involved in benzene-induced apoptosis through regulating apoptosis-related genes expression. Cell Biol. Int. 2011, 35(4):391-396.
12. Greiner J., Ringhoffer M., Simikopinko O., Szmaragowska A., Huebsch S., Maurer U., Bergmann L., Schmitt M. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp. Hematol. 2000, 28(12):1413-1422.
13. Gu T., Gu H.F., Hilding A., Sjöholm L.K., Ostenson C.G., Ekström T.J., Brismar K. Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clin. Epigenetics 2013, 5(1):21.
14. Hou L., Zhang X., Tarantini L., Nordio F., Bonzini M., Angelici L., Marinelli B., Rizzo G., Cantone L., Apostoli P., et al. Ambient PM exposure and DNA methylation in tumor suppressor genes: a cross-sectional study. Part Fibre Toxicol. 2011, 8:25.
15. Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., Cui H., Gabo K., Rongione M., Webster M., Ji H., Potash J.B., Sabunciyan S., Feinberg A.P. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 2009, 41(2):178-186.
16. Irons R.D., Chen Y., Wang X., Ryder J., Kerzic P.J. Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease. Genes Chromosom. Cancer 2013, 52:887-894.
17. Jansen R., Greenbaum D., Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res. 2002, 12:37-46.
18. Ji Z., Zhang L., Peng V., Ren X., McHale C.M., Smith M.T. A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia 2010, 24(5):986-991.
19. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32:D277-D280.
20. Kaymaz B.T., Selvi N., Gündüz C., Aktan C., Dalmizrak A., Saydam G., Kosova B. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis. Ann. Hematol. 2013, 92(2):151-162.
21. Krausz C., Sandoval J., Sayols S., Chianese C., Giachini C., Heyn H., Esteller M. Novel insights into DNA methylation features in spermatozoa: stability and peculiarities. PLoS One 2012, 7(10):e44479.
22. Kuang S.Q., Tong W.G., Yang H., Lin W., Lee M.K., Fang Z.H., Wei Y., Jelinek J., Issa J.P., Garcia-Manero G. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 2008, 22(8):1529-1538.
23. Lagorio S., Ferrante D., Ranucci A., Negri S., Sacco P., Rondelli R., et al. Exposure to benzene and childhood leukaemia: a pilot case-control study. BMJ Open 2013, 3(2).
24. Li C., Li H. Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008, 24:1175-1182.
25. Li G., Yin S. Progress of epidemiological and molecular epidemiological studies on benzene in China. Ann. N. Y. Acad. Sci. 2006, 1076:800-809.
26. Li P., Harris D., Liu Z., Liu J., Keating M., Estrov Z. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 2010, 5(7):e11859.
27. Li Y., Wu X.R., Li X.F., Suriguga, Yu C.H., Li Y.R., Yi Z.C. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone. Toxicology 2013, 312:108-114.
28. Ma L.D., Zhou M., Wen S.H., Ni C., Jiang L.J., Fan J., Xia L. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells. Leuk. Lymphoma 2010, 51(7):1326-1336.
29. Maunakea A.K., Nagarajan R.P., Bilenky M., Ballinger T.J., D'Souza C., Fouse S.D., Johnson B.E., Hong C., Nielsen C., Zhao Y., Turecki G., Delaney A., Varhol R., Thiessen N., Shchors K., Heine V.M., Rowitch D.H., Xing X., Fiore C., Schillebeeckx M., Jones S.J., Haussler D., Marra M.A., Hirst M., Wang T., Costello J.F. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466(7303):253-257.
30. Pearce M.S., McConnell J.C., Potter C., Barrett L.M., Parker L., Mathers J.C., Relton C.L. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int. J. Epidemiol. 2012, 41:210-217.
31. Redell M.S., Ruiz M.J., Alonzo T.A., Gerbing R.B., Tweardy D.J. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor. Blood 2011, 117(21):5701-5709.
32. Sandoval J., Heyn H., Moran S., Serra-Musach J., Pujana M.A., Bibikova M., Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011, 6(6):692-702.
33. Sayed D., Badrawy H., Gaber N. Khalaf MR.p-Stat3 and bcr/abl gene expression in chronic myeloid leukemia and their relation to imatinib therapy. Leuk. Res. 2014, 38(2):243-250.
34. Shen J., Wang S., Zhang Y.J., Wu H.C., Kibriya M.G., Jasmine F., Ahsan H., Wu D.P., Siegel A.B., Remotti H., Santella R.M. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 2013, 8(1):34-43.
35. Smirnikhina S.A., Voronina E.S., Lavrov A.V., Bochkov N.P. Dioxidine-induced changes in genome-wide DNA methylation in a culture of peripheral blood lymphocytes. Bull. Exp. Biol. Med. 2013, 155(2):224-227.
36. Snyder R. Leukemia and benzene. Int. J. Environ. Res. Public Health 2012, 9:2875-2893.
37. Spirin V., Mirny L.A. Protein complexes and functional modules in molecular networks. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12123-12128.
38. Wang X.S., Zhang Y., He Y.H., Ma P.P., Fan L.J., Wang Y.C., Zhang Y.I., Sun D.X., Zhang S.L., Wang C.D., Song J.Z., Yu Y. Aberrant promoter methylation of the CD4 gene in peripheral blood cells of mastitic dairy cows. Genet. Mol. Res. 2013, 12(4):6228-6239.
39. Watkins D.J., Wellenius G.A., Butler R.A., Bartell S.M., Fletcher T., Kelsey K.T. Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation. Environ. Int. 2014, 63:71-76.
40. Wei Z., Li H. A Markov random field model for network-based analysis of genomic data. Bioinformatics 2007, 23:1537-1544.
41. Wright G.W., Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-2455.
42. Yi M., Horton J.D., Cohen J.C., Hobbs H.H., Stephens R.M. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinforma. 2006, 7:30.
43. Zhang J.D., Wiemann S. KEGG graph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 2009, 25:1470-1471.
44. Zhao J., Xu Y., Zong Y., Zhang S., Song Y., Yu K., Li Z., Ji Y., Qiu Y., Chen F. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells. Hematology 2011, 16(4):232-235.
45. Zhong Y., Feng J., Chen B., Cheng L., Li Y., Qian J., Ding J., Gao F., Xia G. Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia. Int. J. Lab. Hematol. 2012, 34(4):383-389.